No Data
S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Truist Secu
H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Cuts Target Price to $60
H.C. Wainwright analyst Patrick Trucchio maintains $Arrowhead Pharmaceuticals(ARWR.US)$ with a buy rating, and adjusts the target price from $90 to $60.According to TipRanks data, the analyst has a su
Arrowhead Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Arrowhead Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Express News | Arrowhead Pharmaceuticals Inc : H.c. Wainwright Cuts Target Price to $60 From $90
HC Wainwright & Co. Maintains Buy on Arrowhead Pharma, Lowers Price Target to $60
HC Wainwright & Co. analyst Patrick Trucchio maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and lowers the price target from $90 to $60.
Form 144 | Arrowhead Pharmaceuticals(ARWR.US) Officer Proposes to Sell 237.41K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 2, $Arrowhead Pharmaceuticals(ARWR.US)$ Officer Oliver Tracie intends to sell 9,394 shares of its common stock on Jul 2, with a total market value of approximately $237.41K